Selonterra, Inc. is a San Francisco Bay Area venture capital funded Delaware corporation.
Selonterra fundamentally transforms therapeutic approaches to neurodegenerative disorders, including Alzheimer’s disease, by a rigorous exploitation of our novel insights into the genetic causes of disease.
Selonterra discovered that the altered DNA of genetic variants associated with neurodegenerative disorders, including Alzheimer’s disease and Parkinson’s disease, affect transcription factor binding sites and thereby change the expression of genes nearby.
In our Alzheimer’s disease program we develop small molecules that modulate the function of an unexploited, druggable target and will fundamentally change Alzheimer’s disease therapy.
We complement our highly relevant extensive experience in start-ups with a global network of specialized collaborator companies and thereby apply state-of-the art technologies to execute our program in a capital efficient way.
Company Details
- Employees
- 3
- Founded
- -
- Address
- 1900 South Norfolk Street,
- ad****@****rra.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- selonterra.com
- Keywords
- R & D, Drug Discovery, Neurodegeneration, Alzheimer's disease, Parkinson's disease, Genetics, Molecular pathways.
- HQ
- San Mateo, California
Selonterra, Inc. Questions
Selonterra, Inc.'s website is selonterra.com
Selonterra, Inc.'s LinkedIn profile is https://www.linkedin.com/company/selonterra-llc
Selonterra, Inc. has
3 employees.
View email and phone details for 3
employees at Selonterra, Inc..
Selonterra, Inc.'s industry is
Biotechnology Research
Selonterra, Inc.'s top competitors are
National Institute Of Neurological Disorders And Stroke (Ninds),
Psychogenics,
Scholar Rock,
Pharmacore Labs,
Nyxoah,
Abbvie,
Pharmanovia,
Shiratronics, Inc.,
Cerevance,
Aviadobio.
Selonterra, Inc.'s support email address is admin@selonterra.com
Selonterra, Inc.'s categories are Biotechnology Research
Selonterra, Inc.'s founding year is 2017
